HROW

Dopo l'orario di chiusura: 37.85 -0.12 -0.32%

Harrow Inc (HROW)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HROW Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Harrow Inc Stock (HROW) Company Profile

Healthcare (1196)

615.733.4731

102 WOODMONT BLVD, NASHVILLE, CA

Prossima data di guadagno

Ultimi documenti SEC

HROW's Discussions on Twitter

Confronta HROW con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HROW	37.97	1.35B	154.15M	-33.58M	-20.74M	-0.56
ZTS	176.42	79.51B	9.15B	2.43B	2.31B	4.92
TAK	13.53	42.89B	30.27B	1.93B	3.45B	0.444
HLN	9.43	42.57B	14.26B	1.55B	0	0.3327
TEVA	16.49	18.51B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.00	15.37B	15.24B	-646.50M	1.88B	1.53

Harrow Inc Stock (HROW) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-09-08	Ripresa	B. Riley Securities	Buy
2021-10-14	Ripresa	B. Riley Securities	Buy
2021-09-24	Iniziato	Aegis Capital	Buy
2021-07-02	Iniziato	Ladenburg Thalmann	Buy

Harrow Inc Borsa (HROW) Ultime notizie

Harrow Inc Azioni (HROW) Dati Finanziari

Harrow Inc (HROW)

Harrow Inc Stock (HROW) Company Profile

Confronta HROW con altri titoli

Harrow Inc Stock (HROW) Upgrades & Downgrades

Harrow Inc Borsa (HROW) Ultime notizie

Harrow, Inc. (NASDAQ:HROW) Stock Position Lessened by Royce & Associates LP - MarketBeat

Harrow Stock: Spotlight On IHEEZO (NASDAQ:HROW) - Seeking Alpha

Harrow (NASDAQ:HROW) Shares Down 7.3%Here's Why - MarketBeat

Harrow Announces Participation in Upcoming Investor Conferences - BioSpace

Harrow Health, Inc. (NASDAQ:HROW) Q3 2024 Earnings Call Transcript - Insider Monkey

Harrow to Present at Major Healthcare Conferences, Including Piper Sandler's Annual Event | HROW Stock News - StockTitan

Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Reven - GuruFocus.com

Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada

Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance

Harrow Inc Com (HROW) Quarterly 10-Q Report - Quartzy

Harrow Grows Revenue 44 Percent in 2024 Third Quarter, Confirms Full-Year Guidance - Vision Monday

Harrow Inc. Reports Strong Q3 2024 Growth - TipRanks

Harrow (NASDAQ:HROW) Shares Gap DownWhat's Next? - MarketBeat

Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Q3 2024 Harrow Inc Earnings Call Transcript - GuruFocus.com

Harrow Inc (HROW) Q3 2024 Earnings: Revenue at $49.3M, Misses Es - GuruFocus.com

Los Angeles Capital Management LLC Sells 38,168 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat

Harrow: Q3 Earnings Snapshot - New Haven Register

Harrow, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Harrow stock plunges 20% on weaker-than-expected Q3 earnings - MSN

Harrow stock plunges 20% on weaker-than-expected Q3 earnings (NASDAQ:HROW) - Seeking Alpha

Harrow (HROW) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

HROWHarrow, Inc. Latest Stock News & Market Updates - StockTitan

Harrow Q3 Revenue Surges 44% to $49.3M as VEVYE Prescriptions Jump 55% | HROW Stock News - StockTitan

Harrow Inc (HROW) Shares Up 6.99% on Nov 13 - GuruFocus.com

Harrow Inc (HROW) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com

Harrow Partners with GoodRx, Cuts Prices on Key Eye Drug Portfolio | HROW Stock News - StockTitan

Harrow Inc (HROW) Stock Price Down 3.18% on Nov 12 - GuruFocus.com

Earnings Outlook For Harrow - Benzinga

Harrow secures Medicare coverage for dry eye treatment VEVYE - Investing.com India

Harrow secures Medicare coverage for dry eye treatment VEVYE By Investing.com - Investing.com UK

Harrow's VEVYE Secures Major Medicare Coverage, Reaching 25M+ Beneficiaries in 2025 | HROW Stock News - StockTitan

Harrow: VEVYE And Its Impact On The DED Market (NASDAQ:HROW) - Seeking Alpha

Equitable Trust Co. Has $2.62 Million Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat

Harrow (HROW) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

Woodmont Investment Counsel LLC Decreases Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat

Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare Products - Business Wire

Best Momentum Stocks To Buy For November 6th - Barchart

Will Harrow (HROW) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

Harrow (HROW) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat

Imprimis Pharmaceuticals, Inc. announced that it has received $3 million in funding from Immy Funding LLC. - Marketscreener.com

Harrow, Inc. (NASDAQ:HROW) Shares Purchased by Rice Hall James & Associates LLC - MarketBeat

Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024 - BioSpace

Harrow (HROW) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN

Wall Street Analysts Believe Harrow (HROW) Could Rally 25.95%: Here's is How to Trade - MSN

Harrow Inc (HROW) Shares Down 3.16% on Oct 29 - GuruFocus.com

Semanteon Capital Management LP Takes $686,000 Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat

Harrow, Inc. (NASDAQ:HROW) Short Interest Update - MarketBeat

Harrow Inc. amends credit agreement, secures $30 million - Investing.com

Harrow Unusual Options Activity For October 28 - Benzinga

Harrow Inc. amends credit agreement, secures $30 million By Investing.com - Investing.com UK

Harrow Inc Azioni (HROW) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a HROW